August 3, 2018 / 7:00 AM / 16 days ago

Spain's Almirall to buy U.S. dermatology portfolio from Allergan

Aug 3 (Reuters) - Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.

Almirall said it would pay $550 million in cash upfront and that there is a possibility of an earn-out of up to $100 million based on business performance.

Reporting by Katarzyna Zajaczkowska in Gdynia; editing by Jason Neely

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below